553. Dual Lipopolysaccharide injection induces prolonged activation of the kynurenine pathway and alters schizophrenia-associated proteins in vivo
C Hillesheim Horst, A Halsen Bidar, Å Wiman, J Ahlberg Weidenfors, T Admyre, V Pálsdóttir, S Erhardt, J Wiseman · 2026
Read 553. Dual Lipopolysaccharide injection induces prolonged activation of the kynurenine pathway and alters schizophrenia-associated proteins in vivo by C Hillesheim Horst, A Halsen Bidar, Å Wiman, J Ahlberg Weidenfors, T Admyre, V Pálsdóttir, S Erhardt, J Wiseman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13556647.txt.
Description
Hillesheim Horst and co-authors test a long-running immune challenge model of schizophrenia in mice in a 2026 study. Two injections of a bacterial toxin switch on the kynurenine pathway and raise a compound also found high in patients. The mice also show memory problems, echoing the illness. What happens past five days was unknown.
The team asked whether the pathway stays switched on at seven days and whether the toxin shifts proteins tied to schizophrenia in brain areas used for thinking. Those proteins matter because current drugs ease the loud symptoms but not the lasting thinking deficits. The study aims to firm up the model for hunting disease-changing treatments.
Catalog record
| CREATOR | C Hillesheim Horst, A Halsen Bidar, Å Wiman, J Ahlberg Weidenfors, T Admyre, V Pálsdóttir, S Erhardt, J Wiseman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |